FDA Warning Letter — Inspire Clinic

Case 715799 — FEI 3039695048

The FDA took a Warning Letter action against Inspire Clinic on Sep 9, 2025 (Grand Prairie, TX). The action was issued by CDER and concerns drugs products.

Action details

Facility
Inspire Clinic
Date
Sep 9, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Grand Prairie, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.